Flolan: Powder for solution for injection (0.5mg)
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
What is this Medicine?
EPOPROSTENOL (e poe PROST en ole) is used to treat primary pulmonary hypertension.
Similar Generic Drugs : Epoprostenol: Powder for solution for injection (1.5mg) | Epoprostenol: Powder for solution for injection (0.5mg)
Flolan 0.5mg Powder for Injection
NDC: 001730517-
Prescription Required
-
Not a Controlled Drug
(CSA Schedule) -
FDA Approved
Scleroderma (systemic Sclerosis)
Sometimes used for but not FDA approved for the following conditions:
Pulmonary Hypertension
Protect from light
Store between 59 to 77 degrees F
Reported Side Effects for Flolan 0.5mg Powder for Injection
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: RAPID
Onset: DELAYED
Onset: EARLY
Onset: RAPID
Onset: RAPID
Onset: RAPID
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Onset: EARLY
Onset: EARLY
Onset: DELAYED
Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.


Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.
- Get answers to Frequently Asked Questions (FAQs)
- Find other class related drugs
- Find additional patient usage statistics
Be the first to share your experience!
We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.


